De-escalating systemic chemotherapy might be considered for pure triple negative apocrine breast cancer patients.
J BUON
; 24(2): 864, 2019.
Article
in En
| MEDLINE
| ID: mdl-31128051
Subject(s)
Search on Google
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Apocrine Glands
/
Antineoplastic Combined Chemotherapy Protocols
/
Practice Guidelines as Topic
/
Triple Negative Breast Neoplasms
Type of study:
Guideline
Limits:
Female
/
Humans
/
Middle aged
Language:
En
Journal:
J BUON
Journal subject:
NEOPLASIAS
Year:
2019
Document type:
Article
Affiliation country:
Turquía
Country of publication:
Chipre